Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 519 for “"neoplasm"”.

  1. Predictive Modeling of Cystic Pancreatic Neoplasm Histology

    … which comprise intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm (MCN), display a greater predisposition for conversion to malignancy as compared to their non-mucinous counterpart serous cystadenoma (SCN). Typically, cystic tumours are diagnosed when they became …

    jhu Repository record for Predictive Modeling of Cystic Pancreatic Neoplasm Histology (opens in a new tab)

  2. Surgical Outcomes for Solid Pseudopapillary Neoplasm of Pancreas

    Background/Aims: Solid pseudopapillary neoplasm (SPN) is a rare exocrine tumor of the pancreas with low malignant potential. This study was designed to evaluate surgical outcome of solid pseudopapillary neoplasm (SPN). Methodology: From Between January 1994 to November 2013, 41 patients were …

    ajou Repository record for Surgical Outcomes for Solid Pseudopapillary Neoplasm of Pancreas (opens in a new tab) Embargoed until 9999-12-31

  3. Beyond prostate-specific antigen: alternatives for prostate neoplasm screening

    Prostate adenocarcinoma (PCa) is one of the most prevalent cancers in the world. Second only to lung cancer, the key to its successful treatment is in its early detection. With the introduction of prostate-specific antigen in the early 1990s, a screening test involving measuring levels of this …

    bu Repository record for Beyond prostate-specific antigen: alternatives for prostate neoplasm screening (opens in a new tab)

  4. Deep learning framework for classification of neuroendocrine neoplasm whole slide images

    Neuroendocrine neoplasms (NENs) are uncommon neoplasms, which can arise in cells across the body. The last few decades have seen NEN incidence increase by 7-fold. NEN grades are morphologically indistinguishable for well-differentiated tumours and are determined from the tumour proliferation. Cell …

    ubc Repository record for Deep learning framework for classification of neuroendocrine neoplasm whole slide images (opens in a new tab) Download PDF for Deep learning framework for classification of neuroendocrine neoplasm whole slide images (opens in a new tab)

  5. Modeling and Therapeutic Development for the Tuberous Sclerosis Related Neoplasm Lymphangioleiomyomatosis

    The multisystemic tumors characteristic of the monogenic neoplastic diseases, tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM), share common signaling aberrations upon the loss of heterozygosity in either the TSC1 or TSC2 genes. However, their physical manifestations are vastly …

    ottawa-retro Repository record for Modeling and Therapeutic Development for the Tuberous Sclerosis Related Neoplasm Lymphangioleiomyomatosis (opens in a new tab)

  6. Improving risk stratification of myeloid neoplasm undergoing allogeneic stem cell transplantation

    Die akute myeloische Leukämie (AML) und das myelodysplastische Syndrom (MDS) stellen heterogene myeloische Neoplasien dar, deren Übergang in einander fließend ist. Während bei der AML ein Differenzierungsblock sowie eine unkontrollierte Proliferation myeloischer Vorläuferzellen dominieren, zeichnet …

    qucosa-diss

  7. PRMT5 IS A POTENTIAL THERAPEUTIC VULNERABILITY IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

    Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and clinically aggressive hematologic cancer that arises from malignant transformation of plasmacytoid dendritic cells (pDCs) and is predisposed to leukemic transformation. A recurrent feature of BPDCN is dysregulated MYC expression, …

    nus Repository record for PRMT5 IS A POTENTIAL THERAPEUTIC VULNERABILITY IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (opens in a new tab) Download file for PRMT5 IS A POTENTIAL THERAPEUTIC VULNERABILITY IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (opens in a new tab)

  8. AI-based Volumetric Analysis of Liver Metastases Load in Neuroendocrine Neoplasm (NEN) Patients

    … with liver metastases from neuroendocrine neoplasms is essential for therapeutic management. However, accurate measurement of three-dimensional (3D) volumes is time-consuming and difficult to achieve. Even though the common criteria for assessing treatment response have simplified the …

    fu-berlin Repository record for AI-based Volumetric Analysis of Liver Metastases Load in Neuroendocrine Neoplasm (NEN) Patients (opens in a new tab)

  9. Treatment of Splanchnic Vein Thrombosis with Anticoagulant Therapy in Patients with Cancer and Myeloproliferative Neoplasm

    … in patients with cancer and myeloproliferative neoplasms (MPN). Approximately 4 to 20% of patients with cancer experience VTE at some disease stage and the overall thrombosis risk is as high as 20% in patients with MPN. VTE includes deep vein thrombosis (DVT) (e.g., lower extremities, splanchnic …

    ottawa-retro Repository record for Treatment of Splanchnic Vein Thrombosis with Anticoagulant Therapy in Patients with Cancer and Myeloproliferative Neoplasm (opens in a new tab)

  10. COMBINED DIAGNOSTIC APPROACHES FOR THE DIAGNOSIS OF CANINE SPLENIC NEOPLASM: CONTRAST-ENHANCED ULTRASONOGRAPHY, ULTRASOUND GUIDED CYTOLOGY, HISTOLOGY AND IMMUNOHISTOCHEMISTRY IN SELECTED LESIONS.

    … evaluation of splenic lesions and specifically neoplasms. The aim of this study was to evaluate the diagnostic usefulness of contrast enhanced ultrasound and cytology in the diagnosis of splenic neoplasia, this study has been divided into a prospective and in retrospective part. The specific aim …

    milano Repository record for COMBINED DIAGNOSTIC APPROACHES FOR THE DIAGNOSIS OF CANINE SPLENIC NEOPLASM: CONTRAST-ENHANCED ULTRASONOGRAPHY, ULTRASOUND GUIDED CYTOLOGY, HISTOLOGY AND IMMUNOHISTOCHEMISTRY IN SELECTED LESIONS. (opens in a new tab)

  11. Descriptive epidemiology and outcome of patients with intraductal papillary mucinous neoplasm (IPMN): a population-based comparison to pancreatic adenocarcinoma and review of literature.

    Intraductal papillary neoplasm (IPMN) is an uncommon cancer of the pancreas, histologically characterized as a distinct entity by WHO in 1996, as noninvasive (adenoma, borderline neoplasm, carcinoma in situ) or invasive. Our understanding of this disease comes mainly from small retrospective …

    utmb Repository record for Descriptive epidemiology and outcome of patients with intraductal papillary mucinous neoplasm (IPMN): a population-based comparison to pancreatic adenocarcinoma and review of literature. (opens in a new tab)

Page 1 of 26